Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of twice daily LEO 124249 ointment for eyebrow alopecia areata
2017-002720-24Phase 2Terminated
- Sponsor
- LEO Pharma
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alopecia areata comparing LEO 124249 ointment 30 mg/g with Vehicle ointment (2 arms). Primary endpoint: Investigator evaluated overall eyebrow area score. Started Aug 2017; status: terminated.
02
Drugs
delgocitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on 2017-002720-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002720-24.